Brief: Axcella Therapeutics Announces $25 Million Registered Direct Offering Of Common Stock Priced At The Market
16/03/2022 12:24
March 16 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA THERAPEUTICS ANNOUNCES $25 MILLION REGISTERED
DIRECT
OFFERING OF COMMON STOCK PRICED AT THE MARKET
* AXCELLA THERAPEUTICS - ENTERED SECURITIES PURCHASE
AGREEMENT
WITH INVESTORS IN REGISTERED DIRECT OFFERING OF 13.1 MILLION
COMMON STOCK AT $1.91/SHARE
Source text for Eikon: ID:nBw7mrtmxa
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment